COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective

Vaccine manufacturers from developing countries have a proven track record of developing, producing, and supplying high-quality vaccines globally. However, due to the complexity of vaccine manufacturing, numerous stakeholder organizations support manufacturers across a variety of functions. To optim...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayman, Benoit, Suri, Rajinder, Prasad, Sai D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275514/
https://www.ncbi.nlm.nih.gov/pubmed/34325932
http://dx.doi.org/10.1016/j.vaccine.2021.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275514/
https://www.ncbi.nlm.nih.gov/pubmed/34325932
http://dx.doi.org/10.1016/j.vaccine.2021.07.007

Ejemplares similares